eye problems with glp 1 GLP-1 Drugs Linked to Lower Risk of TED Danny D. | 👁️ Important

Gastrointestinal side effects like gas and bloating affect up to 25% of patients taking semaglutide

We hope that this tool helps patients with the information they need to start their health journey with GLP-1s.

To conclude, the food intake reducing effects of exenatide may temporally evolve from strong anorectic to weak anhedonic modulations, where hedonic experience and anticipation during the early anorectic phase is conserved but uncoupled from food intake behaviour.

Understanding the clinical rationale, potential risks, and accessible alternatives helps patients make informed decisions about GLP-1 therapy

These patients face a critical problem: they're losing 25-40% muscle mass alongside fat loss, experiencing seve